Casirivimab/imdevimab improve outcomes in early COVID-19
A new Viruses study determines the effect of casirivimab/imdevimab on IFN-1 and cytokines during SARS-CoV-2 infection.
Lightspring Shutterstock Imdevimab Treatment Serum Typei Interferon Levels Image Credit Coronavirus Disease Covid 19 Monoclonal Antibody
Source: news-medical.net